These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toward a meningitis-free world. Black S; Pizza M; Nissum M; Rappuoli R Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923 [TBL] [Abstract][Full Text] [Related]
3. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. Wise J BMJ; 2014 Mar; 348():g2327. PubMed ID: 24665138 [No Abstract] [Full Text] [Related]
5. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774 [No Abstract] [Full Text] [Related]
7. Meningitis: a new vaccine but the vigilance must go on. Glennie L Prof Care Mother Child; 1999; 9(5):121-3. PubMed ID: 10818951 [No Abstract] [Full Text] [Related]
8. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026 [No Abstract] [Full Text] [Related]
10. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention. Esposito S; Castellazzi L; Bosco A; Musio A; Stoddard J Immunotherapy; 2014; 6(4):395-408. PubMed ID: 24815780 [TBL] [Abstract][Full Text] [Related]
11. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Pérez-Trallero E; Vicente D; Montes M; Cisterna R Lancet; 2002 Sep; 360(9337):953. PubMed ID: 12354504 [No Abstract] [Full Text] [Related]
12. Vaccine news: new meningitis vaccine approved for children...and should we be giving all schoolchildren flu vaccine? Child Health Alert; 2005 Mar; 23():1-3. PubMed ID: 15789475 [No Abstract] [Full Text] [Related]
13. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Robbins JB; Schneerson R; Gotschlich EC; Mohammed I; Nasidi A; Chippaux JP; Bernardino L; Maiga MA Bull World Health Organ; 2003; 81(10):745-50; discussion 751-5. PubMed ID: 14758435 [TBL] [Abstract][Full Text] [Related]
14. Meningococcal vaccine use in college students. Kelleher JA; Raebel MA Ann Pharmacother; 2002 Nov; 36(11):1776-84. PubMed ID: 12398576 [TBL] [Abstract][Full Text] [Related]
16. Comparative cost effectiveness supports the use of meningococcal vaccine in schools after a single case. Roberts RJ; Petrovic M J Public Health Med; 1999 Dec; 21(4):480-1. PubMed ID: 11469375 [No Abstract] [Full Text] [Related]
17. Improved meningitis vaccine for Africa could signal eventual end to deadly scourge. Wkly Epidemiol Rec; 2007 Jun; 82(24):222-4. PubMed ID: 17571448 [No Abstract] [Full Text] [Related]
18. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Robbins JB; Towne DW; Gotschlich EC; Schneerson R Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615 [TBL] [Abstract][Full Text] [Related]
19. Safety of group C meningococcal vaccine. Commun Dis Rep CDR Wkly; 2000 Sep; 10(35):311, 314. PubMed ID: 10992627 [No Abstract] [Full Text] [Related]
20. Meningitis B vaccine should not be given to all babies, committee says. Gulland A BMJ; 2016 Jul; 354():i3943. PubMed ID: 27417847 [No Abstract] [Full Text] [Related] [Next] [New Search]